28.6 F
New York
Monday, March 8, 2021

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Must read

Fathom [NASDAQ: FTHM] Announces Purchase Of Real Estate Brokerage Business Of Red Barn

Fathom Holdings Inc. revealed that the company has purchased the residential real estate brokerage business of Red Barn Real Estate. Additionally, The Real...

Neilsen [NYSE: NLSN] Reports Completion Of The Divestiture Of Global Connect Business

Nielsen Holdings plc revealed that the company has finished the recently reported sale of NielsenIQ to associates of Advent International, in collaboration with...

Chipotle [NYSE: CMG] Collaborates With e.l.f [NYSE: ELF] To Launch Limited-Edition Makeup Collection

Chipotle and e.l.f. beauty is collaborating on March 10 to dispatch the limited edition e.l.f. x Chipotle collection. e.l.f's devotion to cruelty-free...

Jabil Healthcare [NYSE: JBL] Announces Strategic Partnership With E3D

Jabil Healthcare, a subsidiary of Jabil Inc. , revealed that the company has inked a partnership contract with E3D.  It is a worldwide drug...

Haemonetics Corporation [NYSE: HAE] revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an upfront payment of $475Million in cash to purchase Cardiva. Furthermore, based on the sales growth the company will pay an additional payment of $35million in conditional consideration.

Cardiva is a California based vascular closure system manufacturer. The portfolio of the company consists of two vascular access site closure devices bases on the catheter. The VASCADE and the VASCADE MVP vascular closure system. The former is designed to treat small-bore femoral and arterial-venous closure Meanwhile the latter is designed to treat mid-bore multi-access femoral venous closure.

VASCADE MVP is the only existing devices that the FDA has approved for the use of cardiac ablation procedures. The acquisition will close in 2021’s first quarter. Moreover, from this acquisition, nearly $65M to $75 M income will be generated in the first fiscal year.  

Cris Simon CEO and president of Haemonetics said “ we are glad to add Cardiva Medical team t our family. We are also really excited to add their technology to our portfolio which expands our hospital offerings”.

More articles

Latest article

XpresSpa Group [NASDAQ: XSPA] Inked An Agreement With The Port Of Seattle For A Covid-19 Testing Facility

XpresSpa Group, Inc. a wellbeing and health organization, reported that it has entered into an agreement with the Port of Seattle. The contract...

Zepp Health [NYSE: ZEPP] Announces Expanded Collaboration With Rouumtech

Zepp Health Corp. revealed that the company has expanded its collaboration with Rouumtech Co Ltd.  The contract initially expanded to reach to private label...

Netflix [NASDAQ: NFLX] Rolls Out Fast Laughs Featuring Comedy Bits

Netflix, In revealed through its newsroom the addition of a new feature on its mobile app. The Fast laugh is the new feature...

AT&T [NYSE: T] Enters Into A Contract To Divest Its Government Solution Business

AT&T announced that the company inked an agreement to divest its Government Solution Business (GSI). Tyto Athene will purchase the government solution including...

Sino-Global [NASDAQ: SINO] Announces The Execution Of Purchase Agreement Of 2783 Digital Currency Operating Server

Sino-Global Shipping America reported that the company is going to process the execution of the purchase agreement. The company purchased 2783 digital currency...

Commercial Vehicle Group [NASDAQ: CVGI] To Collaborate With Xos Inc

Commercial Vehicle Group revealed that the company entered into a collaboration with Xos, Inc. Furthermore, Xos is a leading commercial electric vehicle manufacturer....

Upland Software [NASDAQ: UPLD] Announces The Acquisition Of BlueVenn

Upland Software, Inc. revealed that the company has purchased BlueVenn. It is a cloud-based client data platform(CDP). With BlueVenn, Upland clients can now...

Columbus McKinnon [NASDAQ: CMCO] Inks An Agreement To Purchase Dorner

Columbus McKinnon Corporation today reported that the Company has executed an authoritative consent to secure Dorner Manufacturing Corporation. Dorer is an automation solution...